Passive immunotherapy may prevent HIV, laboratory tests suggest

08/28/2014 | (India)

A study supported by the National Institutes of Health found that passive immunotherapies that use broadly neutralizing antibodies could prevent the transmission of HIV. In a laboratory experiment, researchers found that the PGT121, VRC01 and VRC03 antibodies stopped the virus from entering CD4+ T cells obtained from HIV-negative volunteers.

View Full Article in: (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC